Medibank shares on ice as details of cyberattack emerge

Medibank has been targeted by hackers…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Medibank has been hit with a cyberattack
  • No customer data is believed to have been accessed at this stage
  • Medibank is working around the clock to understand the full nature of the incident

Medibank Private Ltd (ASX: MPL) shares won't be going anywhere on Thursday.

This morning the private health insurer requested a trading halt until the commencement of trade on Monday.

What's going on with Medibank shares?

Medibank shares have been put on ice today after the private health giant became the latest company to be targeted by a cyberattack.

Hot on the heels of the Optus attack, Medibank revealed that it detected unusual activity on its network on Wednesday

In response, the company took immediate steps to contain the incident, and engaged specialised cyber security firms.

The good news is that, at this stage, there is no evidence that any sensitive data, including customer data, has been accessed by the intruder.

Though, customers are likely to face some disruption in the immediate term. The release notes that Medibank will be isolating and removing access to some customer-facing systems to reduce the likelihood of damage to systems or data loss.

At this stage, the company's AHM and international student policy management systems have been taken offline and are expected to remain that way for most of the day.

Though, Medibank's health services continue to be available to customers, including their ability to access their health providers.

'Working around the clock'

Medibank's CEO, David Koczkar, commented:

I apologise and acknowledge that in the current environment this news may make people concerned. Our highest priority is resolving this matter as transparently and quickly as possible. We will continue to take decisive action to protect Medibank Group customers and our people.

We recognise the significant responsibility we have to the people who rely on us to look after their health and wellbeing and whose data we hold. We are working around the clock to understand the full nature of the incident, and any additional impact this incident may have on our customers, our people and our broader ecosystem.

Investigations are ongoing, and Medibank intends to provide regular updates.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Is this beaten-down ASX healthcare share a bargain buy now?

One expert has given their view on this stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »

A young man goes over his finances and investment portfolio at home.
Healthcare Shares

Down 20%, is the NIB share price undervalued?

Here's what Goldman Sachs is saying about this blue chip stock.

Read more »

four excited doctors with their hands in the air
Healthcare Shares

Sigma Healthcare shares rocket 39% on Chemist Warehouse merger approval

The ACCC doesn't believe the company's merger with Chemist Warehouse will lessen competition.

Read more »